Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2026年1月9日
	新闻
	FDA approves AstraZeneca's lung cancer drug - The Pharma Letter The Pharma Letter The US Food and Drug Administration (FDA) has approved AstraZeneca's non-small cell lung cancer (NSCLC) treatment Tagrisso (osimertinib), ... 标记为不相关
	US FDA approves Pfizer lung cancer drug Xalkori and companion diagnostic from Abbott The Pharma Letter The US Food and Drug Administration has approved global drugs behemoth Pfizer’s (NYSE: PFE) Xalkori (crizotinib) to treat certain patients with ... 标记为不相关
	ACT Brief: EU Comparator Drug Sourcing Pressures, AI Expands Its Role in Oncology Trials ... Applied Clinical Trials ... cancer and SWOG on a large biomarker-driven small cell lung cancer trial. And in a recent Pharmaceutical Executive video interview, Trialynx ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈